Application progress of percutaneous ablation therapy of renal angiomyolipoma
10.13929/j.1672-8475.201811038
- Author:
Xinfei LI
1
Author Information
1. Department of Interventional Radiology and Vascular Surgery, Peking University First Hospital
- Publication Type:Journal Article
- Keywords:
Blood vessels;
Catheter ablation;
Kidney neoplasms;
Lipoma;
Myocytes, smooth muscle
- From:
Chinese Journal of Interventional Imaging and Therapy
2019;16(7):430-433
- CountryChina
- Language:Chinese
-
Abstract:
Renal angiomyolipoma (AML) is a kind of benign tumor of the kidney. In the past years, partial nephrectomy and selective arterial embolization were preferentially performed on AML patients with obvious symptom or the largest diameter of tumor more than 4 cm. Recently, percutaneous ablation therapy is applied to treat renal AML, which has some advantages of small impact on renal function, less complications and low recurrence rate, but the relevant evidences are not yet sufficient. The advancements of radiofrequency ablation, microwave ablation and cryoablation in treatment of renal AML were reviewed in this article.
